1The First Affiliated Hospital of Hainan Medical College, Hainan, China
2GE Healthcare (China), Beijing, China
Presenting Author: Zijing Lin
Synopsis
Motivation:
Goals:
Approach:
Results:
Preview figure
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public on 13 May 2028.
To request or purchase access, contact the ISMRM Central Office at support@ismrm.org.
1. Htet H, Anaghan JRJ, Jaiprakash H, et al. Efficacy and safety of molecular targeted therapies in nasopharyngeal carcinoma: a network meta-analysis. BMC Cancer. 2025; 25(1): 1-13. https://doi.org/10.1186/s12885-025-13528-y [doi]
2. Wang Z, Feng M, Zhang J, et al. Radiomics and deep learning in nasopharyngeal carcinoma: a review. IEEE Reviews in Biomedical Engineering. 2023; 17: 118-135. https://doi.org/10.1109/RBME.2023.3269776 [doi]
3. 3Jin X, Li WZ, Guo YH, et al. Predicting progression-free survival using dynamic contrast-enhanced imaging-based radiomics in advanced nasopharyngeal carcinoma patients treated with nimotuzumab. European Radiology. 2025; [in press]: 1-11. https://doi.org/10.1007/s00330-025-11433-3 [doi]
4. 4Li Q, Yu Q, Gong B, Ning Y, Chen X, Gu J, Lv F, Peng J, Luo T. The effect of magnetic resonance imaging based radiomics models in discriminating stage I-II and III-IVa nasopharyngeal carcinoma. Diagnostics (Basel). 2023; 13(2): 300. https://doi.org/10.3390/diagnostics13020300. PMID: 36673110; PMCID: PMC9857437 [doi][pmid]